AI assistant
Adicet Bio, Inc. — Director's Dealing 2020
Sep 18, 2020
34412_dirs_2020-09-17_3c57ee77-aad1-438b-b6a9-31a9e4d5e8af.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2020-09-15
Reporting Person: Krehlik Carrie (Chief Human Resources Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-09-15 | Employee Stock Option (right to buy) | $2.26 | A | 18600 | Acquired | 2027-12-13 | Common Stock (18600) | Direct |
| 2020-09-15 | Employee Stock Option (right to buy) | $5.97 | A | 15450 | Acquired | 2029-10-15 | Common Stock (15450) | Direct |
| 2020-09-17 | Incentive Stock Option (right to buy) | $16.11 | A | 40391 | Acquired | 2030-09-17 | Common Stock (40391) | Direct |
Footnotes
F1: 25% of the option vested on November 27, 2018, and 1/36th of the remaining unvested option vests on each of the next thirty-six (36) monthly anniversaries thereafter, provided that Ms. Krehlik remains in continuous service as of the applicable vesting date.
F2: Received in exchange for an employee stock option to acquire 150,000 shares of common stock of Adicet Bio, Inc., a Delaware corporation ("Old Adicet"), for $0.280 per share in connection with the merger (the "Merger") of Old Adicet with and into Project Oasis Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of resTORbio, Inc., a Delaware corporation ("resTORbio"). On the effective date of the Merger, resTORbio changed its name to "Adicet Bio, Inc."
F3: 1/48th of the option vests on each of the forty-eight (48) monthly anniversaries of October 15, 2019, provided that Ms. Krehlik remains in continuous service as of the applicable vesting date.
F4: Received in exchange for an employee stock option to acquire 124,600 shares of common stock of Old Adicet for $0.740 per share in connection with the Merger.
F5: 1/48th of the shares of common stock subject to the option shall vest on each of the forty-eight (48) monthly anniversaries of the vesting commencement date, provided that Ms. Krehlik remains in continuous service as of the applicable vesting date.